Papers by Anna Hofmann · AgingResearch.News

The Lancet Neurology24 Sep
Dynamic changes in plasma biomarkers of Alzheimer's disease in patients treated with lecanemab: a longitudinal cohort study
Study in peopleInterventions
Paper
CNS Drugs15 Sep
From Proof of Principle to Therapeutic Discipline: Strategies to Improve the Benefit/Risk Profile of Amyloid-Targeting Treatments for Alzheimer's Disease
ReviewInterventions
Paper
Alzheimer's & Dementia14 Aug
Medical comorbidities of patients receiving amyloid-targeting treatments in a memory clinic
Study in peoplePopulations
Paper
AAIC 2025 Abstract24 Dec
Determining eligibility for anti‐amyloid treatments using blood biomarkers
Study in peopleBiomarkers
Paper